The Congenital Heart Disease Genetic Network Study: rationale, design, and early results

Circ Res. 2013 Feb 15;112(4):698-706. doi: 10.1161/CIRCRESAHA.111.300297.

Abstract

Congenital heart defects (CHD) are the leading cause of infant mortality among birth defects, and later morbidities and premature mortality remain problematic. Although genetic factors contribute significantly to cause CHD, specific genetic lesions are unknown for most patients. The National Heart, Lung, and Blood Institute-funded Pediatric Cardiac Genomics Consortium established the Congenital Heart Disease Genetic Network Study to investigate relationships between genetic factors, clinical features, and outcomes in CHD. The Pediatric Cardiac Genomics Consortium comprises 6 main and 4 satellite sites at which subjects are recruited, and medical data and biospecimens (blood, saliva, cardiovascular tissue) are collected. Core infrastructure includes an administrative/data-coordinating center, biorepository, data hub, and core laboratories (genotyping, whole-exome sequencing, candidate gene evaluation, and variant confirmation). Eligibility includes all forms of CHD. Annual follow-up is obtained for probands <1-year-old. Parents are enrolled whenever available. Enrollment from December 2010 to June 2012 comprised 3772 probands. One or both parents were enrolled for 72% of probands. Proband median age is 5.5 years. The one third enrolled at age <1 year are contacted annually for follow-up information. The distribution of CHD favors more complex lesions. Approximately, 11% of probands have a genetic diagnosis. Adequate DNA is available from 97% and 91% of blood and saliva samples, respectively. Genomic analyses of probands with heterotaxy, atrial septal defects, conotruncal, and left ventricular outflow tract obstructive lesions are underway. The scientific community's use of Pediatric Cardiac Genomics Consortium resources is welcome.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Biological Specimen Banks / organization & administration
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Confidentiality
  • DNA Mutational Analysis
  • Data Collection
  • Databases, Factual
  • Follow-Up Studies
  • Gene Dosage
  • Genetic Association Studies
  • Genomics
  • Genotype
  • Heart Defects, Congenital / epidemiology
  • Heart Defects, Congenital / genetics*
  • Hospitals, Pediatric / organization & administration
  • Humans
  • Infant
  • Infant, Newborn
  • Interdisciplinary Communication
  • National Heart, Lung, and Blood Institute (U.S.) / organization & administration*
  • Outcome Assessment, Health Care
  • Patient Selection
  • Phenotype
  • Prospective Studies
  • Registries* / ethics
  • Schools, Medical / organization & administration
  • Translational Medical Research / organization & administration
  • United States
  • Young Adult